India is witnessing a significant surge in heart disease, evidenced by a 50% increase in cardiac medication sales between 2021 and 2025. Experts attribute this rise to better awareness, revised hypertension guidelines, and an aging population. Increased access to care and diagnostic tools also contribute to the higher detection and treatment rates of cardiovascular issues.
India is witnessing a significant surge in heart disease, evidenced by a 50% increase in cardiac medication sales between 2021 and 2025. Experts attribute this rise to better awareness, revised hypertension guidelines, and an aging population. Increased access to care and diagnostic tools also contribute to the higher detection and treatment rates of cardiovascular issues. India is witnessing a significant surge in heart disease, evidenced by a 50% increase in cardiac medication sales between 2021 and 2025. Experts attribute this rise to better awareness, revised hypertension guidelines, and an aging population. Increased access to care and diagnostic tools also contribute to the higher detection and treatment rates of cardiovascular issues.
